EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.07 Billion EUR | 3.12% |
| 2022 | 15.58 Billion EUR | 27.41% |
| 2021 | 12.23 Billion EUR | 44.3% |
| 2020 | 8.47 Billion EUR | -21.65% |
| 2019 | 10.81 Billion EUR | 58.23% |
| 2018 | 6.83 Billion EUR | 57.32% |
| 2017 | 4.34 Billion EUR | 3.95% |
| 2016 | 4.18 Billion EUR | 4.21% |
| 2015 | 4.01 Billion EUR | 21.03% |
| 2014 | 3.31 Billion EUR | 16.81% |
| 2013 | 2.83 Billion EUR | 1.95% |
| 2012 | 2.78 Billion EUR | 19.91% |
| 2011 | 2.32 Billion EUR | 7.5% |
| 2010 | 2.15 Billion EUR | 17.84% |
| 2009 | 1.83 Billion EUR | 4.76% |
| 2008 | 1.74 Billion EUR | 4.49% |
| 2007 | 1.67 Billion EUR | 6.85% |
| 2006 | 1.56 Billion EUR | 12.74% |
| 2005 | 1.38 Billion EUR | 1.98% |
| 2004 | 1.36 Billion EUR | 6.28% |
| 2003 | 1.28 Billion EUR | 0.45% |
| 2002 | 1.27 Billion EUR | 8.77% |
| 2001 | 1.17 Billion EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.2 Billion EUR | 0.0% |
| 2024 Q1 | 4.2 Billion EUR | -46.36% |
| 2023 Q4 | 7.83 Billion EUR | 102.51% |
| 2023 FY | 16.07 Billion EUR | 3.12% |
| 2023 Q1 | 4.04 Billion EUR | -48.56% |
| 2023 Q2 | 8.23 Billion EUR | 103.43% |
| 2023 Q3 | 3.86 Billion EUR | -53.01% |
| 2022 Q2 | 7.72 Billion EUR | 103.1% |
| 2022 FY | 15.58 Billion EUR | 27.41% |
| 2022 Q1 | 3.8 Billion EUR | -44.87% |
| 2022 Q3 | 3.88 Billion EUR | -49.74% |
| 2022 Q4 | 7.86 Billion EUR | 102.65% |
| 2021 Q3 | 3.38 Billion EUR | -37.2% |
| 2021 FY | 12.23 Billion EUR | 44.3% |
| 2021 Q1 | 2.64 Billion EUR | -46.5% |
| 2021 Q2 | 5.38 Billion EUR | 103.36% |
| 2021 Q4 | 6.89 Billion EUR | 104.05% |
| 2020 FY | 8.47 Billion EUR | -21.65% |
| 2020 Q1 | 1.69 Billion EUR | -68.33% |
| 2020 Q2 | 3.54 Billion EUR | 109.7% |
| 2020 Q3 | 2.33 Billion EUR | -34.07% |
| 2020 Q4 | 4.94 Billion EUR | 111.81% |
| 2019 Q3 | 2.62 Billion EUR | -52.12% |
| 2019 FY | 10.81 Billion EUR | 58.23% |
| 2019 Q2 | 5.48 Billion EUR | 103.26% |
| 2019 Q1 | 2.7 Billion EUR | 40.98% |
| 2019 Q4 | 5.33 Billion EUR | 103.04% |
| 2018 Q1 | 1.45 Billion EUR | -18.96% |
| 2018 Q3 | 1.91 Billion EUR | 31.6% |
| 2018 Q4 | 1.91 Billion EUR | 0.0% |
| 2018 FY | 6.83 Billion EUR | 57.32% |
| 2018 Q2 | 1.45 Billion EUR | 0.0% |
| 2017 Q3 | 1.79 Billion EUR | 58.66% |
| 2017 Q2 | 1.13 Billion EUR | 0.0% |
| 2017 Q1 | 1.13 Billion EUR | 10.65% |
| 2017 FY | 4.34 Billion EUR | 3.95% |
| 2017 Q4 | 1.79 Billion EUR | 0.0% |
| 2016 Q2 | 1.06 Billion EUR | 0.0% |
| 2016 FY | 4.18 Billion EUR | 4.21% |
| 2016 Q4 | 1.02 Billion EUR | 0.0% |
| 2016 Q3 | 1.02 Billion EUR | -4.17% |
| 2016 Q1 | 1.06 Billion EUR | 8.32% |
| 2015 Q4 | 985.5 Million EUR | 0.0% |
| 2015 Q2 | 1.02 Billion EUR | 0.0% |
| 2015 Q1 | 1.02 Billion EUR | 18.87% |
| 2015 FY | 4.01 Billion EUR | 21.03% |
| 2015 Q3 | 985.5 Million EUR | -3.43% |
| 2014 Q3 | 858.5 Million EUR | 7.45% |
| 2014 FY | 3.31 Billion EUR | 16.81% |
| 2014 Q1 | 799 Million EUR | 15.05% |
| 2014 Q4 | 858.5 Million EUR | 0.0% |
| 2014 Q2 | 799 Million EUR | 0.0% |
| 2013 Q1 | 724.5 Million EUR | 0.0% |
| 2013 Q2 | 724.5 Million EUR | 0.0% |
| 2013 Q3 | 694.5 Million EUR | -4.14% |
| 2013 Q4 | 694.5 Million EUR | 0.0% |
| 2013 FY | 2.83 Billion EUR | 1.95% |
| 2012 FY | 2.78 Billion EUR | 19.91% |
| 2011 FY | 2.32 Billion EUR | 7.5% |
| 2010 FY | 2.15 Billion EUR | 17.84% |
| 2009 FY | 1.83 Billion EUR | 4.76% |
| 2008 FY | 1.74 Billion EUR | 4.49% |
| 2007 FY | 1.67 Billion EUR | 6.85% |
| 2006 FY | 1.56 Billion EUR | 12.74% |
| 2005 FY | 1.38 Billion EUR | 1.98% |
| 2004 FY | 1.36 Billion EUR | 6.28% |
| 2003 FY | 1.28 Billion EUR | 0.45% |
| 2002 FY | 1.27 Billion EUR | 8.77% |
| 2001 FY | 1.17 Billion EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -945690.936% |
| Ansell Limited | 624.8 Million USD | -2472.023% |
| Ansell Limited | 624.8 Million USD | -2472.023% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -14003.67% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -11898756.022% |
| Psykey, Inc. | 415.97 Thousand USD | -3863103.646% |
| ConvaTec Group Plc | 1.2 Billion USD | -1235.712% |
| ConvaTec Group Plc | 1.17 Billion USD | -1267.892% |
| Encision Inc. | 3.13 Million USD | -512342.434% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -2023796.334% |
| LifePoint, Inc. | -71.35 Thousand USD | 22520350.007% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 12267275.573% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -3060852.381% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -2663848.014% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -2694305.462% |
| SmileDirectClub, Inc. | 275.84 Million USD | -5725.693% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -1684.111% |
| SheerVision, Inc. | 2.17 Million USD | -738441.915% |
| United Health Products, Inc. | -4857.00 USD | 330862772.432% |
| Vasamed, Inc. | -69.38 Thousand USD | 23159724.143% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -6003718.234% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -30521057.791% |